Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

252.95
Delayed Data
As of Jul 29
 -2.61 / -1.02%
Today’s Change
195.50
Today|||52-Week Range
340.34
-19.06%
Year-to-Date
Allergan (AGN) Stock Is Thursday's 'Chart of the Day'
Jul 28 / TheStreet.com - Paid Partner Content
Analysts' Actions -- Allergan, Alaska Air, Tableau, PulteGroup and More
Jul 25 / TheStreet.com - Paid Partner Content
Allergan Cures Its Ailing Chart
Jul 28 / TheStreet.com - Paid Partner Content
Teva taps euro bond market ahead of ECB meeting
Jul 20 / FT.com - Paid Partner Content
Jerome Dodson's Best Investments
Jul 27 / GuruFocus News - Paid Partner Content
What Awaits Boston Scientific (BSX) in Q2 Earnings?
Jul 19 / Zacks.com - Paid Partner Content
Daniel Loeb's Third Point 2nd-Quarter 2016 Investor Letter
Jul 27 / GuruFocus News - Paid Partner Content
Hologic (HOLX) Q3 Earnings: A Surprise in the Cards?
Jul 19 / Zacks.com - Paid Partner Content
3 Stocks Improving Performance Of The Health Care Sector
Jul 26 / TheStreet.com - Paid Partner Content
Illumina (ILMN) to Report Q2 Earnings: What's in the Cards?
Jul 19 / Zacks.com - Paid Partner Content
Jerome Dodson Comments on Allergan
Jul 26 / GuruFocus News - Paid Partner Content
Teva finalises bond sale of up to $16bn
Jul 18 / FT.com - Paid Partner Content
Jerome Dodson's Parnassus Fund 2nd Quarter Commentary
Jul 26 / GuruFocus News - Paid Partner Content
Shire boosted by FDA approval of dry eye drug
Jul 12 / FT.com - Paid Partner Content
Jim Cramer -- I Agree With the Analysts on Gap, Allergan
Jul 25 / TheStreet.com - Paid Partner Content